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Abstract
Background: Ensuring that evidence based medicine reaches patients with diabetes in the US and internationally
is challenging. The chronic care model includes evidence based management practices which support evidence
based care. However, despite numerous studies, it is unclear which practices are most effective. Few studies assess
the effect of simultaneous practices implemented to varying degrees. The present study evaluates the effect of
fifteen practices applied concurrently and takes variation in implementation levels into account while assessing the
impact of diabetes care management practices on glycemic and lipid monitoring.
Methods: Fifteen management practices were identified. Implementation levels of the practices in 41 medical
centres caring for 553,556 adults with diabetes were assessed from structured interviews with key informants.
Stepwise logistic regression models with management practices as explanatory variables and glycemic and lipid
monitoring as outcome variables were used to identify the diabetes care practices most associated with high
performance.
Results: Of the 15 practices studied, only provider alerts were significantly associated with higher glycemic and
lipid monitoring rates. The odds ratio for glycemic monitoring was 4.07 (p < 0.00001); the odds ratio for lipid
monitoring was 1.63 (p < 0.006). Weaker associations were found between action plans and glycemic monitoring
(odds ratio = 1.44; p < 0.03) and between guideline distribution and training and lipid monitoring (odds ratio =
1.46; p < 0.03). The covariates of gender, age, cardiac disease and depression significantly affected monitoring rates.
Conclusions: Of fifteen diabetes care management practices, our data indicate that high performance is most
associated with provider alerts and more weakly associated with action plans and with guideline distribution and
training. Lack of convergence in the literature on effective care management practices suggests that factors
contributing to high performance may be highly context-dependent or that the factors involved may be too
numerous or their implementation too nuanced to be reliably identified in observational studies.
Background
Diabetes mellitus is among the leading chronic diseases
in the US and internationally [1,2]. Complications of
diabetes can be reduced through appropriate medical
care and behavior modification [3,4]. Ensuring that
patients with diabetes receive evidence based care to
control disease and reduce the risk of complications is a
significant challenge; muche v i d e n c ee x i s t so ft h eg a p
between optimal care and the actual care patients
receive [5,6]. The chronic care model advocates an evi-
dence based approach for disease management [7-9].
The model proposes several evidence based manage-
ment practices organised in six interrelated elements
supporting the implementation of evidence based medi-
cine [10,11].
It is essential to know which combinations of practices
are most effective at improving diabetes care. Results
from meta-analyses, randomized controlled trials,
reviews and observational studies evaluating the impact
of management practices on diabetes care are conflict-
ing, presenting divergent results; important issues
regarding the chronic care model and the practices
embedded within it remain unresolved [12-16].
A systematic review assessing the effect of manage-
ment practices in diabetes care concluded that profes-
sional and organizational practices, individually and in
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Adding patient education and or improving the role of a
nurse led to improved care outcomes. Few studies assess
the effects of individual management practices when
several practices are applied at the same time and ana-
lysed with multivariate statistical models [14-16,18-21].
Kerr has recommended that conflicting results among
observational studies of care management could be
addressed via a study design in which specific practices
are carefully defined and the degree of practice imple-
mentation is consistently measured across diverse set-
tings and compared to the outcomes delivered. The
study reported here implements that approach [22].
We studied care management practices in a large U.S.
integrated health care delivery system that has been
recognized as a relatively high quality provider. It pro-
vides comprehensive care to several million members,
including more than 500,000 adults with diabetes.
Within this organisation, decentralized operating units
result in variability in the way components of the
chronic care model are implemented and in the relative
emphasis on each component. Implementation varies
between centers and for individual components within
centers; consequently, local population care programs
differ across the system.
The organisation has invested in standardized mea-
surement of numerous quality indicators to enable com-
parisons over time and across operating units. Internal
reporting shows variations in performance on process
and outcome measures. Variability in population care
practices and performance, together with standardized
measurements, provide a ripe opportunity for learning
about the impact of the chronic care model on diabetes
care processes.
The purpose of this study was to identify management
practices that affect glycemic and lipid monitoring in
diabetes care in the context of several concurrent care
management practices implemented at varying levels.
We chose to use monitoring rates as our outcomes as
they are solely a function of provider decision-making.
Methods
We conducted a cross-sectional observational study. We
identified fifteen diabetes population care management
practices by reviewing the literature on diabetes care
and the Chronic Care Model. These are briefly
described in Table 1. The extent of implementation of
each practice was assessed at each medical center by a
survey administered to a key informant. Survey items
were mainly drawn or adapted from existing instru-
ments, including the Assessment of Chronic Illness
Care, the National Survey of Physician Organizations,
and the Translating Research into Action for Diabetes
instruments [23-25].
We interviewed one key informant at each of the 41
sites at the integrated health care delivery system. Most
k e yi n f o r m a n t sw e r en o n - p h y sician managers responsi-
ble for population based care or diabetes care; some
were physician champions for diabetes care. Survey
items elicited factual information rather than beliefs or
opinions, and key informants were well positioned to
provide the requested information.
We developed algorithms to summarize detailed sur-
vey information into fifteen summary scores represent-
ing distinct population management practices. Three
population care experts blinded to the data weighted
individual items to form summary practice scores ran-
ging from a minimum of 0 to a maximum of 1. More
extensive implementation resulted in a higher score.
The range of implementation scores for 15 population
management practices across 41 sites is shown in Table 2.
Data was registered one year after the interviews took
place, as we wanted to be sure that the practices were
well-implemented and had exerted their effects.
Glycemic monitoring rate was defined as the percen-
tage of members with diabetes who had one or more
glycated hemoglobin (HbA1c) tests during one calendar
year. Lipid monitoring rate was defined as the percen-
tage of members with diabetes who had one or more
low density lipoprotein-C (LDL-C) tests during one
calendar year.
Person-level data on monitoring status were aggre-
gated into strata defined by medical center (41 cate-
gories), age group (4 categories), gender, presence/
absence of depression, and presence/absence of cardio-
vascular disease, and monitoring rates were calculated
for all strata. Of the 1312 possible location-age-gender-
comorbidity combinations, 1198 combinations were
populated by one or more individuals. These 1198 strata
were the units of observation for our analyses, with the
outcome variables expressed as monitoring rates.
As we had only 41 medical centres and a large num-
ber of explanatory variables, we used stepwise regression
analysis to obtain reasonably parsimonious models that
were not overly parameterized. Care management prac-
tices were used as explanatory variables in a forward
selection, stepwise logistic regression model, with ran-
dom effects of medical centers and the observation level
and dependent variables of glycemic and lipid monitor-
ing rates. The medical center random effect captured
excess variability between the 41 medical centers and
played a major role in the statistical analysis in that it
accounted for the medical center clustering effect of
observations, hence providing the proper unbiased error
estimates. The medical center random effect captured
excess variability between the 41 medical centers and
played a major role in the statistical analysis. The obser-
vation level random effect captured overdispersion in
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Practice Definition Items
Health System Organization
Financial Incentives Amount of physician salary at risk, subject to assessment of performance on population care quality
indicators.
4
Provider Feedback Reports to providers about performance and degree of blinding to all providers. 40
Self-Management Support
Patient Action Plans Individual goal setting supported by action plans including needs assessment, personalization, and regular
clinician review.
4
Patient Education Education and support services based on self-management principles in a variety of formats. 35
Delivery System Design
Defined Care Path An explicit protocol or model guides population care. 4
Risk Stratification Use of an algorithm to stratify patients by risk level and determine the level of proactive care provided. 4
Outreach/Follow-Up Proactive, planned care. 19
Inreach Customized reminders for patients of needed care whenever they present for service. 5
Care Coordination Processes and structures supporting effective patient care handoffs, including explicit protocols and
accountabilities.
6
Cultural Competence Care tailored to the needs of major racial, ethnic, and cultural groups. 15
Team Accountability Accountability for patient care vested in care teams rather than individuals. 1
Decision Support
Guideline Distribution
and Training
Distribution of evidence-based guidelines and clinician training on guideline content, including electronic
availability, continuing medical education, and inter-provider communications.
5
Provider Alerts Customized, context-sensitive paper-based or electronic alerts reminding providers of appropriate care for
individual patients and groups of patients.
28
Clinical Information Systems
Registry Completeness and quality of a registry or database of key indicators for all patients with diabetes. 72
Electronic Medical
Record
Availability and comprehensiveness of clinical data during patient visits. 36
Table 2 Variation in diabetes population care practice scores across sites
Care Management Practices Mean Low Score High Score Standard Deviation
Health System Organization
Financial Incentives 0.01 0.00 0.60 0.07
Provider Feedback 0.53 0.00 1.00 0.30
Self-Management Support
Patient Action Plans 0.37 0.00 0.77 0.19
Patient Education 0.61 0.17 0.91 0.17
Delivery System Design
Defined Care Path 0.37 0.08 0.70 0.14
Risk Stratification 0.82 0.17 1.00 0.21
Outreach and Follow-Up 0.74 0.38 0.84 0.14
Inreach 0.57 0.00 1.00 0.43
Care Coordination 0.70 0.10 1.00 0.26
Cultural Competence 0.72 0.20 1.00 0.22
Team Accountability 0.63 0.00 1.00 0.34
Decision Support
Guideline Distribution and Training 0.73 0.23 1.00 0.18
Provider Alerts 0.58 0.00 1.00 0.22
Clinical Information Systems
Registry 0.71 0.64 0.81 0.06
Electronic Medical Record 0.70 0.00 1.00 0.46
Note: Average performance cannot be meaningfully compared between practices due to practice-specific scoring algorithms.
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independent variables and covariates do not completely
explain the excess variation in outcomes [26]. The ran-
dom effects associated with medical centres and obser-
vation levels were similar in both models, with rather
high and comparable dispersion.
Each outcome was modeled separately, assessing the
degree of association between various practices and the
specific process measure. The models were fitted and
compared by maximum likelihood methods using the
“lmer” function of R. Even though we had a large num-
ber of explanatory variables and relatively few medical
centers, our analysis did not demonstrate multicollinear-
ity to an extent that would have made our models
unstable.
Results
The 41 practice sites provided care for 553,556 adults
with diabetes, 51% of which were male. Among patients
with diabetes, 16% were also diagnosed with coronary
artery disease (CAD) and 13% with depression. Four
percent of patients with diabetes were 18 to 34 years of
age, 18% were 35 to 49 years old, 38% were 50 to
64 years old, and 40% were aged 65 years and up. The
mean HbA1c was 7.2% (55 mmol/mol) and the mean
LDL-C level was 105.1 mg/dl (2.72 mmol/L).
The regression models showed that provider alerts
significantly affected the likelihood of both glycemic
and lipid monitoring. This care management practice,
in which providers received reminders of appropriate
care delivered as computerized prompts or paper chart
attachments, had a strong effect on both glycemic and
lipid monitoring rates, increasing the odds ratios for
glycemic monitoring by 4.07 (p < 0.00001) and for
lipid monitoring by 1.63 (p < 0.0006) (Table 3). Sites
that scored highest on this practice had automated,
computerized alerts integrated into electronic medical
records.
Two other practices affected monitoring rates. Guide-
line distribution and training increased the likelihood of
glycemic monitoring; the odds ratio was 1.46 (p < 0.03).
Action plans increased the likelihood of lipid monitor-
ing; the odds ratio was 1.44 (p < 0.03).
The covariates of gender, age, CAD, and depression
affected monitoring rates in both models. Gender differ-
ences for monitoring rates decreased with increasing age
(Table 4). The combined effect of depression and age
resulted in statistically higher odds ratios for both types
of monitoring for members up to 64 years of age, while
odds ratios were lower for those who were 65 or older
(0.95 and 0.87) (Table 5). The combined effect of CAD
and age only affected the likelihood of glycemic moni-
toring in adults between the ages of 50 and 64, the odds
ratio was 1.18 (p < 0.0001). The combined effect of
CAD and gender increased the likelihood of lipid moni-
toring significantly in both men and women.
In summary, the models for glycemic and lipid moni-
toring showed highly consistent effects; we interpret this
finding as genuine because the implementation level of
provider alerts differed across sites for these outcomes.
Discussion
We assessed the individual effects of fifteen concurrently
and variably implemented population care practices on
two diabetes process of care measures. Provider alerts
increased the likelihood of glycemic and lipid monitor-
ing to a statistically significant degree. The effects of
Table 3 Parameter estimates, odds ratios, and P-values for the three significant management practices
Glycemic monitoring
model
Lipid monitoring
model
Parameter
estimate
Odds
ratio
P-value Parameter
estimate
Odds
ratio
P-value
Provider alert 1,4 4,07 > 0.00001 0,49 1,63 0.0006
Guideline distribution and training 0,38 1,46 0.03
Action plans 0,36 1,44 0.03
Practices not significantly related to monitoring outcomes are omitted.
Table 4 Parameter estimates, odds ratios, and P-values
for age and sex and their interactions
Glycemic monitoring
model
Lipid monitoring
model
Parameter
estimate
Odds
ratio
P-value Parameter
estimate
Odds
ratio
P-value
Age 18-34 -0,63 0,53 0.0003 -0,07 0,93 0.52
Age 35-49 -0,23 0,8 0.18 0,53 1,7 < 0.0001
Age 50-64 0,12 1,13 0.49 0,98 2,67 < 0.0001
Age 65up 0,29 1,34 0.09 1,2 3,32 < 0.0001
Age 18-34
female
-0,56 0,57 < 0.0001 -0,47 0,62 < 0.0001
Age 35-49
female
-0,17 0,84 < 0.0001 -0,13 0,88 < 0.0001
Age 50-64
female
0,08 1,08 0.005 0,09 1,1 0.0006
Age 65up
female
-0,08 0,93 0.002 -0,06 0,94 0.02
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significant at a level well below that of provider alerts.
Other studies support our finding that female gender
is associated with lower quality of care for diabetes and/
or cardiovascular disease [27-29]. Notably, we found
that gender differences disappeared with increasing age.
In our study, increasing age was markedly associated
with higher monitoring rates, contradicting evidence
that it is associated with poorer quality of care [30].
Overall, our data suggest that care might be more
strongly affected by patient characteristics than by
guideline recommendations.
Strengths of our study included the very large popula-
tion managed at the care sites we studied and our ability
to quantify the effect of practices taking implementation
levels into account as recommended by Kerr [22]. Lim-
itations to our study included the relatively narrow var-
iation across sites; homogeneity of care management
practices throughout the integrated health care delivery
system stems from multiple factors, including clustering
of sites within operationally consistent regions.
Other limitations are inherent in the observational
study design, including the difficulty of measuring
implementation levels and the large number of unmea-
sured factors and interactions that influence outcomes
in real-world settings. Measuring implementation levels
is a challenging endeavour about which relatively little
has been written [14,15]. More interviews with different
health professionals with a variety of competencies and
understandings of provided care might have improved
the understanding of the implementation level of the
management practices. However, because the interviews
covered diverse aspects of care, many respondents gath-
ered information from colleagues in preparation for the
interview, so the single interviews typically integrate
input from several individuals. We generally found that
we could assess the degree to which structures and pro-
cesses were in place to support each practice, but not
their quality, highlighting the possibility of measurement
error. To understand the practices in greater detail, we
also conducted a series of case studies on diabetes care
at four sites [31]. However, we were unable to complete
a detailed assessment at all 41 sites.
Our results are best interpreted in the context of pre-
vious related studies. Provider alerts creating point-of-
care reminders have been previously identified as an
effective strategy for improving diabetes care
[14,16,17,32-34]. Varying effects of action plans and
guideline distribution and training are shown in the lit-
erature [14,16,17,35-38].
Another study using multivariate statistical modelling,
The Translating Research into Action for Diabetes
(TRIAD) study of approximately 9000 patients, exam-
ined the association between intensity of disease man-
agement by physicians and diabetes process and
outcomes measures [25]. The TRIAD study identified an
association between physician reminders and both lipid
and glycemic monitoring rates: however, the same effect
was noted for two other practices, structured care man-
agement and performance feedback, for which we did
not find an association with monitoring rates.
In a multivariate study conducted in the U.S. Veterans
Health Administration, four other practices affected a
composite process measure of quality (monitoring tests
and physical examinations): the level of support for
guideline efforts, regional office leadership for guideline
use, hospital use of guideline performance data, and
hospital culture [16]. Other studies assessing the impact
Table 5 Parameter estimates, odds ratios and P-values for age and sex and comorbidities the three significant
management practices
Glycemic monitoring
model
Lipid monitoring
model
Parameter
estimate
Odds
ratio
P-value Parameter
estimate
Odds
ratio
P-value
Age 18-34 and depression 0,3 1,34 < 0.0001 0,29 1,33 < 0.0001
Age 35-49 and depression 0,34 1,41 < 0.0001 0,31 1,37 < 0.0001
Age 50-64 and depression 0,19 1,21 < 0.0001 0,22 1,25 < 0.0001
Age 65up and depression -0,05 0,95 0.08 -0,14 0,87 < 0.0001
Age 18-34 and CAD 0,2 1,22 0.41
Age 35-49 and CAD 0,11 1,11 0.03
Age 50-64 and CAD 0,17 1,18 < 0.0001
Age 65up and CAD -0,02 0,98 0.39
Female and CAD 0,74 2,1 < 0.0001
Female and CAD 0,51 1,67 < 0.0001
Coronary artery disease (CAD).
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relying on multivariate statistical models have identified
a variety of practices as important to quality
[15,16,18-21]. Financial incentives have attracted much
attention but did not have significant impact on the
screening rates for HbA1c values nor for LDL-Choles-
terol. Recent studies show mixed results of financial
incentives regarding quality of care improvements
[39-41].The physician financial incentives in place at the
time of this study were small (less than 3% of total phy-
sician income). In sum, the literature is characterized by
inconsistent findings regarding effective management
practices in diabetes care.
Several factors may explain the lack of conclusive evi-
dence. Comparability between studies is poor. Defini-
tions of care management practices vary, and the
Cochrane Collaboration suggests aligning these [32].
However, even across our study sites, we were not able
to ensure consistency in the operational definitions of
care management practices because they had been
developed at the local level within the integrated health
care delivery system over many years.
Another cause of conflicting results in the existing lit-
erature may be the effect of organisational and cultural
contexts on the frontline delivery of diabetes care.
These factors are very challenging to measure and ana-
lyze, and we did not attempt to do so.
Future research identifying effective management
practices should build on the methods we used, includ-
ing measurement of implementation levels and multi-
variate statistical models to assess the effects of multiple
practices implemented in combination. Future efforts
should also seek to align definitions of management
practices, implementation levels, and outcome variables.
The effects of patient-level covariates and organisational
context should be taken into consideration.
The purpose of research attempting to identify specific
practices most associated with better outcomes is to
inform future quality improvement efforts; scarce
resources would arguably be most efficiently allocated to
those practices. This vein of research essentially
attempts to “reverse engineer” critical performance dri-
vers so they can be disseminated broadly or further
amplified. However, conflicting results from observa-
tional care management studies suggest that this
approach may not be the best way to identify or priori-
tize improvement opportunities; context dependencies
and implementation details may preclude identifying
performance drivers via observational studies. Quality
improvement teams should consider other approaches.
Two sound alternatives are based on “learning from
improvement": using rapid-cycle improvement methods
and/or identifying high-performing sites with similar
organisational contexts from which structures and pro-
cesses can be adopted [42].
Conclusions
The diabetes care management practice of provider
alerts improved glycemic and lipid monitoring rates in
patients with diabetes. Action plans and guideline distri-
bution and training also affected monitoring rates,
although to a lesser degree. The covariates of gender,
age, CAD and depression also impacted monitoring
rates to a statistically significant degree, individually and
in combination.
Our findings contribute to a knowledge base that con-
tains somewhat sparse and often conflicting results.
Observational studies with uncontrolled variation on
multiple factors may be inadequate for identifying the
practices that could contribute most to ongoing
improvement in population care, and quality improve-
ment teams should also consider other methods for
identifying improvement opportunities.
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